Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML.
Geoffrey L UyLaura F NewellTara L LinStuart L GoldbergMatthew J WieduwiltRobert J RyanStefan FaderlJeffrey E LancetPublished in: Blood advances (2022)